[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 34.204.173.45. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
October 1982

Acute Nonlymphoblastic Leukemia in a Patient Treated for Brain Tumor

Author Affiliations

From the Department of Neurology, Hôpital Erasme (Dr Hildebrand); the Department of Internal Medicine, Institut Jules Bordet (Drs Malarme and Stryckmans); and the Department of Neuropathology, University of Brussels (Dr Flament-Durand); Brussels.

Arch Neurol. 1982;39(10):664-665. doi:10.1001/archneur.1982.00510220062016
Abstract

• A 39-year-old man died of acute nonlymphoblastic leukemia (ANLL). At age 35, he had undergone an operation for a frontal astrocytoma (grade 4), and received a 6,000-rad cranial irradiation, followed by intensive chemotherapy combining teniposide (VM-26) plus lomustine and 2,4-diamino-5-4'-dichlorophenyl-6-methylpyrimidine (DDMP). This new case of ANLL occurring as a second neoplasm in a patient previously treated for a malignant brain tumor is considered to be related to the antineoplastic therapy.

×